Page last updated: 2024-10-28
gyki 52466 and Neurodegenerative Diseases
gyki 52466 has been researched along with Neurodegenerative Diseases in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kapus, G | 1 |
Székely, JI | 1 |
Durand, J | 1 |
Ruiz, A | 1 |
Tarnawa, I | 1 |
Other Studies
1 other study available for gyki 52466 and Neurodegenerative Diseases
Article | Year |
---|---|
AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Epilepsy; Excitator | 2000 |